Repetitive Transcranial Magnetic Stimulation Plus Reactivation Therapy Efficacy on PTSD Symptom Severity in Resistant PTSD - Trial NCT06111976
Access comprehensive clinical trial information for NCT06111976 through Pure Global AI's free database. This phase not specified trial is sponsored by Assistance Publique - Hôpitaux de Paris and is currently Not yet recruiting. The study focuses on Post Traumatic Stress Disorder. Target enrollment is 102 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Repetitive Transcranial Magnetic Stimulation (rTMS)
Interventional
procedure
Sponsor & Location
Assistance Publique - Hôpitaux de Paris
Timeline & Enrollment
N/A
Dec 01, 2023
Jul 01, 2026
Primary Outcome
PTSD severity score measured at M1 after 12 sessions of rTMS or sham rTMS and simultaneous reactivation of traumatic memory
Summary
A French multicenter randomized and double blinded shamed controlled study recruiting
 patients who present resistant PTSD. The aim of this trial is to assess the efficacy of
 cerebral modulation by rTMS with simultaneous reactivation of traumatic memory on the PTSD
 symptoms at M1.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT06111976
Non-Device Trial